Pharmafile Logo
Pharmafocus logo
Advanced Search
viagra_tablette

Pfizer and Eli Lilly defeat lawsuit over claims Viagra and Cialis cause cancer

April 9, 2020
Business Services Pfizer, viagra

Pfizer and Eli Lilly have defeated a class action lawsuit seeking billions in damages over claims that Viagra and Cialis …

News
hydoxyyy

US reports increase in Hydroxychloroquine misuse

April 9, 2020
Business Services COVID-19, Donald Trump, coronavirus, hydroxychloroquine

The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria …

News
shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020
Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …

News
90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …

News
mcintyre-headshot

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …

Appointment
sage_logo

Sage Therapeutics to halve its total workforce in radical cost-cutting move

April 8, 2020
Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …

News
000_cdcdc

COVID-19 less severe in paediatric patients, according to the CDC

April 8, 2020
Research and Development COVID-19, coronavirus

The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …

News
insulin

Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19

April 8, 2020
Research and Development Eli Lilly, diabetes, insulin

Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …

News
partnership

Second Genome to help drive development of Gilead therapies in potential $1.5bn deal

April 8, 2020
Research and Development Gilead, Second Genome, pharma

Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …

News
00000000_trumpyy

Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers

April 8, 2020
Research and Development COVID-19, coronavirus, covid 19, hydroxychloroquine

Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has …

News

Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials

April 7, 2020
Manufacturing and Production COVID-19, coronavirus, coronavirus vaccine

Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New …

News

Martin Shkreli asks to be furloughed from prison to work on COVID-19 treatments

April 7, 2020
Manufacturing and Production COVID-19, Pharma Bro, coronavirus

Disgraced biotech entrepreneur Martin Shkreli, also known as the ‘Pharma Bro’, is asking for a brief furlough from prison to …

News
stock-incyte-01-shutter

Incyte’s ruxolitinib cream formulations look strong in Phase 3 atopic dermatitis

April 7, 2020
Manufacturing and Production, Research and Development Incyte, atopic dermatitis, ruxolitinib

Incyte has lifted the curtain on promising new Phase 3 data for its 0.75% and 1.5% twice daily cream formulations …

News
modi

Donald Trump talks of “retaliation” if India does not export hydroxychloroquine to the US

April 7, 2020
Manufacturing and Production American coronavirus, COVID-19, Donald Trump, coronavirus

United States President Donald Trump has suggested that the US may retaliate if India did not export the anti-malaria drug …

News
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020
Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …

News
fda2outsideweb

FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence

April 6, 2020
Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …

News
00000000_kockk

British Health Secretary says more patients with COVID-19 are needed for clinical trials

April 6, 2020
Sales and Marketing COVID-19, UK, clinical trials, coronavirus

Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials …

News
novo_nordisk_flag

European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes

April 6, 2020
Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma

The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …

News
00000000_trumpyy

Trump again tells people to take Hydroxychloroquine to treat COVID-19, despite a lack of evidence

April 6, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydrochloroquine, hydroxychloroquine

President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its …

News

Pfizer scores EU approval for MabThera biosimilar Ruxience

April 6, 2020
Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar

The European Commission has moved to authorise Ruxience, Pfizer’s biosimilar version of MabThera (rituximab).  The decision marks the seventh biosimilar …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026